Effectiveness of Rosuvastatin at Preventing the Progression of Atherosclerosis in HIV Positive Patients
Status:
Terminated
Trial end date:
2013-03-01
Target enrollment:
Participant gender:
Summary
Rosuvastatin is a drug used to lower cholesterol, which also has other cardiovascular
benefits. The goal of this project is to determine if rosuvastatin is effective at slowing
the development of heart disease in people with HIV. We expect that after 2 years of
treatment people treated with rosuvastatin will show significantly better results than people
treated with a placebo.